MuCoMiD:一个用于miRNA-Disease关联预测的多任务卷积学习框架
MuCoMiD: A Multitask Convolutional Learning Framework for miRNA-Disease Association Prediction
摘要:
最近的研究表明,microRNA或miRNA可以作为各种复杂人类疾病的生物标志物。由于湿实验室实验昂贵且耗时,近年来用于miRNA-疾病关联预测的计算技术引起了很多关注。数据稀缺是构建可靠的机器学习模型的主要挑战之一。数据稀缺加上使用预先计算的手工输入功能,导致了过度拟合和数据泄漏的问题。我们克服了现有作品的局限性,提出了一种新的多任务图卷积为基础的方法,我们称之为MuCoMiD。MuCoMiD允许自动特征提取,同时将来自五个异质生物信息源(miRNA/疾病与蛋白质编码基因(PCG)之间的相互作用、蛋白质编码基因之间的相互作用、miRNA家族信息和疾病本体)的知识结合在多任务设置中,这是一个新颖的视角,以前没有研究过。为了有效地测试我们的模型的泛化能力,我们在标准基准数据集以及我们提出的更大的独立测试集和案例研究上构建了大规模的实验。MuCoMiD在HMDDv2.0和HMDDv3.0数据集上的5倍CV评估中显示出至少3%的改善,并且在具有不可见miRNA和疾病的较大独立测试集上显示出至少35%的改善。我们在https://git.l3s.uni-hannover.de/dong/cmtt上分享我们的代码,用于再现性和未来的研究。
英文摘要:
Growing evidence from recent studies implies that microRNA or miRNA could serve as biomarkers in various complex human diseases. Since wet-lab experiments are expensive and time-consuming, computational techniques for miRNA-disease association prediction have attracted a lot of attention in recent years. Data scarcity is one of the major challenges in building reliable machine learning models. Data scarcity combined with the use of precalculated hand-crafted input features has led to problems of overfitting and data leakage. We overcome the limitations of existing works by proposing a novel multi-tasking graph convolution-based approach, which we refer to as MuCoMiD. MuCoMiD allows automatic feature extraction while incorporating knowledge from five heterogeneous biological information sources (interactions between miRNA/diseases and protein-coding genes (PCG), interactions between protein-coding genes, miRNA family information, and disease ontology) in a multi-task setting which is a novel perspective and has not been studied before. To effectively test the generalization capability of our model, we construct large-scale experiments on standard benchmark datasets as well as our proposed larger independent test sets and case studies. MuCoMiD shows an improvement of at least 3% in 5-fold CV evaluation on HMDDv2.0 and HMDDv3.0 datasets and at least 35% on larger independent test sets with unseen miRNA and diseases over state-of-the-art approaches. We share our code for reproducibility and future research at https://git.l3s.uni-hannover.de/dong/cmtt.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。